Whitethorn For House

Politics For All Parties

Family Man turned CEO of Ovations Pharmaceuticals LLC: Jeff Aronin

How Jeff Aronin Chartered Innovation Through Paragon Biosciences: Recap


Jeff Aronin is an individual that eventually would have to make an ultimate decision on how to treat his patients ailments. He had a child in his care who was suffering from seizures. The choice between treating this condition with surgery (that could be a rough recovery) or a medication was a tough call to make. Aronin eventually decided to go the route of medication to avoid the possible complications due to surgery. Jeff Aronin believes that building a relationship with his patients is very crucial step to further his career. It’s his patients that motivated him to become the Chief Executive Officer and creator of Ovations Pharmaceuticals LLC.


In the beginning Jeff Aronin received his Bachelors Degree through Northern Illinois University. He later obtained his Masters of Business Administration through DePaul University. He soon began a career in the healthcare field. He later discovered he could better help people obtain the medication they needed through the pharmaceutical industry. He created Ovations Pharmaceuticals LLC in the early 2000’s. He wanted to be able to fully focus his career on drug development and the patients needs. What was going to make his pharmaceutical company stand out from others was that his focus was to address the specific needs of the patients. Especially the patients who had rare diseases or diseases with little to no cure. He wanted to be able to make a difference for those people.


In 2009 a Danish company named Lundbeck offered to buy Aronin’s pharmaceutical company for just under one billion dollars. Lundbeck decided the smart thing to do was to continue allowing Aronin to be the CEO of Ovations Pharmaceuticals LLC. This company still continues to be a huge success story and to think it’s all because of a physician who wanted to make a difference in the treatment of his patients.


Jorge Moll Gives Thoughts On Effects Of Technology In Healthcare

The day will soon be at hand when physicians will be able to access all the information of a patient they are treating with a single voice command.


Jorge Moll, a neuroscientist and President of the D’Or Institute, says that technological innovation is a rapidly growing trend across the globe and is causing it to become impossible to have a discussion regarding the healthcare industry without talking about the benefits of technology.


Moll, who is from Brazil, says that the many technological advances made in the United States like have spilled over into the healthcare industry. Moll also fondly recalled a visit he and the D’Or Institute received from Dr. Albert Chan, of Sutter Health, who has become the largest network for healthcare in Northern California.


Jorge Moll says that the work Dr. Chan and Sutter Health is doing mirrors the work of the D’Or Institute in that it utilizes new technologies to improve the patient experience.


While in Rio De Janeiro, Chan spoke about major trends in the industry and expressed a passion to instruct others on how technology can be used to improve the way patients receive care.


Jorge Moll is in agreement with Dr. Chan and says that aligning medicine with technology is benefitting physicians upon initial consultation with patients because never before has an entire patient history been available to a doctor with a voice command. Google Glass is currently being used to provide this technology.


Moll also says this technology also improves interaction between patient and doctor because now that doctors no longer have the need to dig through mountains of files to access information, more time can be spent and more attention can be paid to patients.


Jorge Moll says that the process is becoming much more efficient as all information is stored remotely after a patient consultation and is available for review immediately by a specialist. The increased productivity allows the physician to provide a different level of both convenience and interaction that patients are responding to in a favorable way. Moll also reports on the trend that is seeing smartphones and tablets playing a larger roll in the retrieval of patient information.